• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	101,000	30.09.24 10:00:32	-1,000	-0,98%	101,200	101,800	101,800	102,000
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	86,500	30.09.24 09:08:45	-2,000	-2,26%	86,500	87,500	86,500	88,500